The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Premature BirthInfant, Very Low Birth WeightBronchopulmonary Dysplasia
Interventions
DRUG

Montelukast

a leukotriene D4 receptor antagonist; sodium salt is the active compound; structure in first source

Trial Locations (1)

443-721

Ajou university medical center, Suwon

All Listed Sponsors
collaborator

Severance Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Korea University

OTHER

lead

Ajou University School of Medicine

OTHER

NCT01717625 - The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia | Biotech Hunter | Biotech Hunter